<?xml version="1.0" encoding="UTF-8"?>
<ref id="B17">
 <label>17.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Xia</surname>
    <given-names>S</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Liu</surname>
    <given-names>M</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Wang</surname>
    <given-names>C</given-names>
   </name>
  </person-group>
  <etal/>
  <article-title>Inhibition of SARS-CoV-2 infection (previously 2019-nCoV) by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion</article-title>. 
  <source>bioRxiv</source>. (
  <year>2020</year>). 
  <pub-id pub-id-type="doi">10.1101/2020.03.09.983247</pub-id>
 </mixed-citation>
</ref>
